Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2. [PDF]
Syndecans are transmembrane heparan sulphate proteoglycans. Their role in the development of the malignant phenotype is ambiguous and depends upon the particular type of cancer.
Bálint Péterfia +11 more
doaj +2 more sources
Early plasma syndecan-1 dynamics and their prognostic value in major thoracic and abdominal surgery: a prospective observational study [PDF]
Background Glycocalyx degradation, reflected by syndecan-1 shedding, is implicated in microcirculatory dysfunction and inflammatory responses. The present study aimed to assess early postoperative changes in plasma syndecan-1 levels following major ...
Lysha M. Laurens +5 more
doaj +2 more sources
Serum syndecan-1 is related to severity and prognosis of COVID-19 patients: a perspective cohort study [PDF]
Introduction Syndecan-1 is one of cell surface proteoglycans that mediates the connection between cytoskeleton and interstitial matrix. The previous studies have demonstrated that syndecan-1 exerts an essential role in several pulmonary diseases. However,
Mengmeng Ma +10 more
doaj +2 more sources
Aqueous humor levels of syndecan-1 and syndecan-4 associated with OCTA metrics in diabetic retinopathy [PDF]
PurposeAttenuated endothelium glycocalyx had been shown to be related to vascular damage during diabetic retinopathy (DR). Syndecans were pivotal components of retinal glycocalyx, which could be released from the endothelial surface by a highly regulated
Jixian Ma +10 more
doaj +2 more sources
Serum Syndecan-1 is Associated With Kidney and Cardiovascular Outcomes in Idiopathic Nephrotic Syndrome [PDF]
Introduction: Idiopathic nephrotic syndrome (INS) is associated with important kidney and cardiovascular morbidities. We tested the hypothesis that serum syndecan-1, a marker of endothelial glycocalyx injury, can help identify patients at risk for ...
Colin Bauer +10 more
doaj +2 more sources
Syndecan-1 as a Biomarker for Cardiovascular Risk in Patients with Behçet’s Disease [PDF]
Background/Aims: This study aimed to assess the potential of syndecan-1 levels as a biomarker for diagnosing cardiovascular diseases and atherosclerosis in patients with Behçet’s disease.
Cengiz Kadıyoran +6 more
doaj +2 more sources
Syndecan-1, endocan and non-culprit coronary plaque composition following non-ST elevation myocardial infarction [PDF]
Background: Syndecan-1 and endocan are biomarkers of endothelial damage, which associate with worse outcomes after myocardial infarction (MI). As it is unclear how this is mediated, we investigated how they associate with the composition of residual, non-
Naomi E. Wattchow +9 more
doaj +2 more sources
Serum expression of ESM-1 and Syndecan-1 and its relationship with disease severity in children with Mycoplasma pneumoniae pneumonia [PDF]
Background This study aim to investigate the role of endothelial damage in the pathogenesis of Mycoplasma pneumoniae pneumonia (MPP) by comparing serum levels of endothelial cell-specific molecule 1 (ESM-1) and Syndecan-1 in patients with varying degrees
Yanjuan Yu +5 more
doaj +2 more sources
Syndecan-1 and E-Cadherin Expression in Canine Cutaneous Squamous Cell Carcinoma [PDF]
Cutaneous squamous cell carcinoma (CSCC) in dogs is a locally invasive tumor that typically occurs in areas of poorly pigmented skin due to sun exposure.
Rita Files +4 more
doaj +2 more sources
Syndecan-1 and syndecan-4 are members of the syndecan family of transmembrane heparan sulfate proteoglycans. Vascular endothelial cells synthesize both species of proteoglycans and use them to regulate the blood coagulation-fibrinolytic system and their ...
Takato Hara +3 more
doaj +1 more source

